Fresenius medical care grows number of u.s. patients using company's home hemodialysis machines, launches nxstage® versi®hd with guideme software

Fresenius medical care achieves growth milestone of more than 14,000 u.s.-based patients using the company's nxstage systems to perform home hemodialysis therapy this growth has generated greater adoption from a range of dialysis providers and delivers on the company's commitment to grow access to and use of home dialysis therapy the newest nxstage® versi®hd with guideme software home dialysis machine is designed to simplify treatment, increase ease of learning, and improve user experience waltham, mass. , sept. 4, 2024 /prnewswire/ -- fresenius medical care (fme), a global leader in kidney care, has achieved a growth milestone of more than 14,000 u.s.-based patients using the company's nxstage systems to perform home hemodialysis (hhd) therapy through both fresenius kidney care clinics and other providers.
FMS Ratings Summary
FMS Quant Ranking